Toggle light / dark theme

Excitonium has a team of researchers at the University of Illinois at Urbana-Champaign… well… excited! Professor of Physics Peter Abbamonte and graduate students Anshul Kogar and Mindy Rak, with input from colleagues at Illinois, University of California, Berkeley, and University of Amsterdam, have proven the existence of this enigmatic new form of matter, which has perplexed scientists since it was first theorized almost 50 years ago.

The team studied non-doped crystals of the oft-analyzed transition metal dichalcogenide titanium diselenide (1T-TiSe2) and reproduced their surprising results five times on different cleaved crystals. University of Amsterdam Professor of Physics Jasper van Wezel provided crucial theoretical interpretation of the experimental results.

So what exactly is excitonium?

Read more

Scientists at the École polytechnique fédérale de Lausanne (EPFL) have found a way to make mitochondria more resistant to damage, which could potentially be used to halt Alzheimer’s and other, similar, diseases.

Globally, Alzheimer’s disease is the most common form of dementia and cause of neurodegeneration. It causes brain damage and symptoms such as long-term memory loss. It is an amyloid-based disease, with the characteristic hallmark being the formation of toxic plaques in the brain made from the aggregated beta-amyloid inside the neurons.

Read more

But the F-35 program, usually not one to shy away from boasting about their achievements, has been hushed about the prospect of defeating one of the gravest threats to the US.

“I can tell you that the F-35 is a multi-mission fighter,” Commander Patrick Evans of the Office of the Secretary of Defense told Business Insider when asked about the program. “It would be inappropriate to speculate on future capabilities or missions of the weapon system.”

Rep. Duncan Hunter, a member of the House Armed Services Committee, was more open to speculating about why the Pentagon hadn’t gone through with missile intercepting planes.

Read more

In a bold first-of-its-kind experiment, scientists have edited a person’s genes directly inside living tissue in an ambitious bid to cure a man of a rare, crippling genetic disorder.

While CRISPR has broken ground in things like editing human embryos and injecting patients with genetically edited cells, this alternative technique pioneers a new real-time approach to infusing a person’s blood with a gene-editing virus.

“For the first time, a patient has received a therapy intended to precisely edit the DNA of cells directly inside the body,” says CEO of Sangamo Therapeutics, Sandy Macrae, whose company is testing the experimental procedure.

Read more

Thirty-seven years after Dr. Amar Bose hit on the idea of beefing up a loudspeaker’s electromagnetic driver to be an adaptive car suspension, Bose is selling off the technology to ClearMotion, another Boston-area tech company founded by MIT graduates. Bose got as far as developing prototype cars that were exhibited in 2004, though it did bring to market an offshoot, electromagnetically suspended seats for long-haul truck drivers.

Read more